DE3266294D1 - Method for the preparation of antigens of the viral hepatitis nanb, and application to the preparation of a reaction agent allowing the diagnosis and prognosis of infections caused by the viruses of viral hepatitis - Google Patents

Method for the preparation of antigens of the viral hepatitis nanb, and application to the preparation of a reaction agent allowing the diagnosis and prognosis of infections caused by the viruses of viral hepatitis

Info

Publication number
DE3266294D1
DE3266294D1 DE8282900965T DE3266294T DE3266294D1 DE 3266294 D1 DE3266294 D1 DE 3266294D1 DE 8282900965 T DE8282900965 T DE 8282900965T DE 3266294 T DE3266294 T DE 3266294T DE 3266294 D1 DE3266294 D1 DE 3266294D1
Authority
DE
Germany
Prior art keywords
preparation
viral hepatitis
prognosis
antigens
viruses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8282900965T
Other languages
English (en)
Inventor
Christian Trepo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Christian Trepo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Christian Trepo filed Critical Christian Trepo
Application granted granted Critical
Publication of DE3266294D1 publication Critical patent/DE3266294D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE8282900965T 1981-03-30 1982-03-30 Method for the preparation of antigens of the viral hepatitis nanb, and application to the preparation of a reaction agent allowing the diagnosis and prognosis of infections caused by the viruses of viral hepatitis Expired DE3266294D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8106385A FR2502154A1 (fr) 1981-03-30 1981-03-30 Procede de preparation d'antigenes de l'hepatite virale nanb, et application a la realisation d'un reactif permettant le diagnostic et le pronostic des infections provoquees par les virus des hepatites virales
PCT/FR1982/000060 WO1982003330A1 (en) 1981-03-30 1982-03-30 Method for the preparation of antigens of the viral hepatitis nanb,and application to the preparation of a reaction agent allowing the diagnostic and pronostic of infections caused by the viruses of viral hepatitis

Publications (1)

Publication Number Publication Date
DE3266294D1 true DE3266294D1 (en) 1985-10-24

Family

ID=9256801

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8282900965T Expired DE3266294D1 (en) 1981-03-30 1982-03-30 Method for the preparation of antigens of the viral hepatitis nanb, and application to the preparation of a reaction agent allowing the diagnosis and prognosis of infections caused by the viruses of viral hepatitis

Country Status (4)

Country Link
EP (1) EP0074986B1 (de)
DE (1) DE3266294D1 (de)
FR (1) FR2502154A1 (de)
WO (1) WO1982003330A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4542016A (en) * 1981-03-27 1985-09-17 Institut Merieux Non-a non-b hepatitis surface antigen useful for the preparation of vaccines and methods of use
JPS57198867A (en) * 1981-06-02 1982-12-06 Eisai Co Ltd Non-a, non-b hepatitis related antigen and diagnostic therefor
JPS58753A (ja) * 1981-06-25 1983-01-05 Eisai Co Ltd 非ａ非ｂ型肝炎関連抗体および検出試薬
JPS58183629A (ja) * 1982-04-21 1983-10-26 Eisai Co Ltd 非ａ非ｂ型肝炎関連モノクロナ−ル抗体および診断薬
WO1984001107A1 (en) * 1982-09-16 1984-03-29 Gen Hospital Corp Non a, non b hepatitis virus, methods of identification, purification, characterization, diagnosis and immunization
DE3316464A1 (de) * 1983-05-05 1984-11-08 Heinrich Prof Dr Med Liehr Virusantigen, verfahren zu seiner gewinnung und anwendung in diagnose und therapie (impfstoff)
US4673634A (en) * 1985-03-08 1987-06-16 The United States Of America As Represented By The Department Of Health And Human Services Purified antigen from non-A, non-B hepatitis causing factor
FR2597606B1 (fr) * 1986-04-16 1989-10-06 Pasteur Institut Nouveau reactif pour la detection d'hepatites virales non a non b et procede de diagnostic de telles hepatites par voie immunoenzymatique
FR2609807B2 (fr) * 1987-02-11 1992-05-29 Pasteur Institut Reactifs immunologiques pour la detection de l'hepatite virale nanb, leurs procedes de preparation et leurs applications dans des procedes de detection de l'hepatite virale nanb et en tant qu'agents therapeutiques
NZ222465A (en) * 1986-11-07 1992-11-25 Pasteur Institut Nanb (non a, non b hepatitis viral) antigen
FR2606515B1 (fr) * 1986-11-07 1992-02-21 Pasteur Institut Procede pour l'isolement d'un nouvel agent viral et de l'antigene qui lui est associe, agent viral et antigene obtenus par ce procede et procede de detection dudit antigene a l'aide d'un reactif immunologique approprie
DE3744242A1 (de) * 1987-02-20 1989-07-06 Seelig Renate Virusantigen, verfahren zu seiner gewinnung und anwendung in diagnose und therapie (impfstoff)
YU48038B (sh) * 1987-11-18 1996-10-18 Chiron Corp. Postupak za dijagnostiku ne-a, ne-v hepatitisa
US5698390A (en) * 1987-11-18 1997-12-16 Chiron Corporation Hepatitis C immunoassays
US5714596A (en) * 1987-11-18 1998-02-03 Chiron Corporation NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
US6171782B1 (en) 1987-11-18 2001-01-09 Chiron Corporation Antibody compositions to HCV and uses thereof
US5712088A (en) * 1987-11-18 1998-01-27 Chiron Corporation Methods for detecting Hepatitis C virus using polynucleotides specific for same
US6861212B1 (en) 1987-11-18 2005-03-01 Chiron Corporation NANBV diagnostics and vaccines
US6027729A (en) * 1989-04-20 2000-02-22 Chiron Corporation NANBV Diagnostics and vaccines
US6815160B1 (en) 1999-07-28 2004-11-09 Chiron Corporation Hepatitis C viral antigen immunoassay detection systems
DE60033190T2 (de) * 1999-07-28 2007-10-31 Novartis Vaccines and Diagnostics, Inc., Emeryville Verfahren zum nachweis von hepatitis c antigenen
DE102007046271A1 (de) 2007-09-20 2009-04-02 Sitech Sitztechnik Gmbh Anordnung eines Gurtretraktors an einem Gurtintegralsitz

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1105178A (en) * 1965-11-17 1968-03-06 Andreas Lembke Improvements in or relating to antigens suitable for the diagnosis of hepatitis
US4356164A (en) * 1979-05-21 1982-10-26 Govt. of the U.S., as represented by the Secretary, Dept. of Health & Human Services Detection of non-A, non-B hepatitis associated antigen
JPS57198867A (en) * 1981-06-02 1982-12-06 Eisai Co Ltd Non-a, non-b hepatitis related antigen and diagnostic therefor
JPS58753A (ja) * 1981-06-25 1983-01-05 Eisai Co Ltd 非ａ非ｂ型肝炎関連抗体および検出試薬

Also Published As

Publication number Publication date
WO1982003330A1 (en) 1982-10-14
EP0074986B1 (de) 1985-09-18
FR2502154A1 (fr) 1982-09-24
FR2502154B1 (de) 1984-01-27
EP0074986A1 (de) 1983-03-30

Similar Documents

Publication Publication Date Title
DE3266294D1 (en) Method for the preparation of antigens of the viral hepatitis nanb, and application to the preparation of a reaction agent allowing the diagnosis and prognosis of infections caused by the viruses of viral hepatitis
DE3176404D1 (en) Vaccine against viral hepatitis b, method and transformed eucaryotic cells for the preparation of this vaccine
LTIP1793A (en) Method for detecting antibodies against hiv virus
ZA826154B (en) Infectious bronchitis vaccines for poultry, process for the preparation of such vaccines, process for preventing infectious broachitis and infectious bronchitis virus strain
IT8247706A0 (it) Procedimento per la produzione di virus vaccini
AU8273487A (en) Viral agent for nanb hepatitis, antigen and immunologic reagent
AU8223187A (en) T cell epitopes of the hepatitis b virus nucleocapsid protein
AU506385B2 (en) Hepatitis b virus; isolation for vaccines
YU140380A (en) Process for obtaining dna fragment of hepatitis b virus
GB2199328A (en) Translation of mrna
DE3262970D1 (en) Process and catalyst for the preparation of cyclic imines
EP0232921A3 (en) Monoclonal antibodies against hepatitis b virus
DE3175955D1 (en) Process for the deternination of antigens or antibodies
DE3474775D1 (en) Method for purification of hepatitis b virus surface antigen
DE3071225D1 (en) Influenza virus vaccines, process for preparing them and process for propagating influenza viruses
DE3160264D1 (en) Process for isolating viral glycoproteic antigens, and its use in the preparation of vaccines
GB2111829B (en) A process for the preparation of lyophilized vaccine against duck hepatitis
EP0185391A3 (en) Method for the purification of the hbc antigen and method for the measurement of hbc antibodies by using said purified hbc antigen
DE3275998D1 (en) Immunological composition and method for hepatitis b virus
ZA878303B (en) A process for isolating and characterizing a new viral agent and its associated antigen,the antigen and viral agent obtained by this process,and detection procedures for non a,non b hepatitis using suitable immunological reagents
GB2064322B (en) Process for purifying particles of biological origin particularly the surface antigen of the virus of hepatitis b (aghbs)
EP0119259A4 (de) Nicht a, nicht b, hepatitis-virus, verfahren zur bestimmung, reinigung, kennzeichnung, diagnose und immunisierung.
DE3268625D1 (en) Process for the preparation of a cooling emulsion, and its application
GB2181434A (en) Hepatitis b virus vaccine and process for its preparation
ZA796944B (en) Vaccines against diseases,caused by reovirus,and process for the preparation of those vaccines

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE M

8381 Inventor (new situation)

Free format text: TREPO, CHRISTIAN, BRON, FR

8339 Ceased/non-payment of the annual fee